Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 35K
2: EX-99 Miscellaneous Exhibit HTML 582K
7: R1 Cover Page HTML 50K
9: XML IDEA XML File -- Filing Summary XML 12K
12: XML XBRL Instance -- pfe-20240501_htm XML 19K
8: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
4: EX-101.DEF XBRL Definitions -- pfe-20240501_def XML 40K
5: EX-101.LAB XBRL Labels -- pfe-20240501_lab XML 77K
6: EX-101.PRE XBRL Presentations -- pfe-20240501_pre XML 40K
3: EX-101.SCH XBRL Schema -- pfe-20240501 XSD 12K
10: JSON XBRL Instance as JSON Data -- MetaLinks 14± 20K
11: ZIP XBRL Zipped Folder -- 0000078003-24-000103-xbrl Zip 72K
Registrant’s telephone number, including area code:
(i212) i733-2323
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
i☐ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
Stock, $0.05 par value
iPFE
iiNew York Stock Exchange/
i1.000%
Notes due 2027
iPFE27
iiNew York Stock Exchange/
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
The information furnished pursuant to this “Item 2.02 - Results of Operations and Financial Condition”, including Exhibit 99, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by us under the Exchange Act or Securities Act of 1933, as amended, regardless of any general incorporation language in any such filing, except as shall be expressly set forth by specific reference in such filing.
Press Release of Pfizer Inc. dated May 1, 2024, reporting Pfizer’s financial results for the first quarter of 2024.
104
Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.